Key Points Glucocorticoids modulate growth hormone (GH) secretion at both the hypothalamic and pituitary level Hypoadrenalism might cause GH deficiency that is reversible during glucocorticoid replacement therapy Testing for GH deficiency in patients with hypopituitarism should always be performed after adequate periods of cortisol replacement Chronic excess of glucocorticoids, either exogenous or endogenous, causes GH deficiency that might be involved in metabolic and cardiovascular complications Treatment with recombinant GH could be considered in children and adults with glucocorticoid-induced GH deficiency This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Whether youre addressing a diagnosed deficiency or simply need a wellness boost, our team is here to help
External resources National Institutes of Health: Regenerative and Protective Actions of GHK-Cu Peptide PubMed: Microneedle-Mediated Delivery of Copper Peptide Through Skin PMC: Ionic Liquid Microemulsions for Topical Peptide Delivery For researchers committed to optimizing their hair restoration protocols, SeekPeptides provides comprehensive resources including detailed protocols, personalized guidance, and community support from thousands of experienced researchers who've navigated these exact questions
Its primary role is to build the biological infrastructure required for healing
Administration of high doses of biotin, and sometimes thiamine, has been shown to result in partial or complete improvement within days
